NAM is the official provider of online scientific reporting for the
8th International AIDS Society Conference on HIV Pathogenesis, Treatment
and Prevention (IAS 2015), which will take place in Vancouver, Canada,
19th-22nd July 2015.

News by topic

Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Tuberculosis and HIV news

Public Health England (PHE) and NHS England have today (19 January 2015) announced an £11.5 million investment as part of a collaborative initiative to decrease TB cases and ultimately eliminate TB as a public health problem in England.

At a press conference convened by the AIDS Healthcare Foundation Ukraine today, a group of patients, experts and activists delivered a strong message that the country is experiencing a preventable tuberculosis (TB) outbreak this year due to the failure of state procurements to obtain essential medications. Activists urged that immediate measures be taken to address the crisis, including distributing needed medical supplies, creating transparent procurement systems and assessing the effectiveness of TB treatment for each patient in accordance to international standards.

Kiev may be facing an unprecedented tuberculosis crisis. This is according to Larissa Kanarovskaya, the Head of the Kiev City Union of health workers. On December 1, 2014, at a press conference (a video in Russian can be seen here), she announced that on the average, 100 people die every day in Ukraine’s capital, of which one case is from active tuberculosis.

The stark figures, published on Thursday, and believed to be the first to quantify the potential impact of antimicrobial resistance (AMR) – drug-resistant infections or superbugs – will be used to make the case to global leaders that urgent action is needed. To put the figures in context there are currently 8.2 million deaths a year from cancer and annual global GDP stands at $70tn to $75tn, with the UK figure around $3tn.

Xpert MTB/RIF testing for pulmonary tuberculosis in a central lab took twice longer than sputum smear microscopy among HIV-positive patients with suspected pulmonary TB in Durban, South Africa. The authors believe Xpert results in “operational delays that limit the test's clinical utility for diagnosing pulmonary TB” in their patients.

In the midst of the current widespread Ebola outbreak, we have to stop and think. What is the next epidemic – and are we already facing it? Even though tuberculosis is treatable, it is spreading rapidly, taking the lives of over 1.5 million people each ...

Filter by country

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.